ImmunoGen to host a conference call to discuss its financial results

Editorial Checklist Reviewed
Oct 22 2009

ImmunoGen, Inc. (Nasdaq:IMGN), a biotechnology company that develops targeted anticancer products, today announced that will host a conference call at 4:30 pm ET on Thursday, October 29, 2009 to discuss the Company’s financial results for the three-month period ended September 30, 2009 – the first quarter of ImmunoGen’s 2010 fiscal year. Management also will provide an update on the Company.

To access the live call by phone, dial 913-312-6698. Passcode is 6451192. The call also may be accessed through the Investor Information section of the Company’s website, www.immunogen.com. Following the live webcast, a replay of the call will be available at the same location through November 5, 2009.

Source:

http://www.immunogen.com/

Posted in:

Tags: , , , ,

Comments (0)

Suggested Reading

New approach shows promise in fighting multiple cancers
Insilico Medicine doses first patient in Phase I Trial of ISM6331 for mesothelioma
Pittcon to make historic first appearance in Boston’s world-leading scientific hub
New approach unveiled to accurately predict and engineer protein metalation
Pheno Therapeutics granted clinical trial authorization for lead multiple sclerosis therapeutic candidate PTD802
MIT breakthrough enables fast and uniform protein labeling in 3D tissues
Spear Bio secures FDA breakthrough device designation for its novel pTau 217 blood test, advancing scalable solutions for early Alzheimer's disease diagnosis
Pheno Therapeutics receives clinical trial authorization for novel multiple sclerosis therapeutic

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Research could lead to better medicines and new tools in synthetic biology